Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

GALE $1.67 0.1500 +9.87%
MTP $4.01 0.3399 +9.26%
EXEL $6.00 0.4400 +7.91%
LXRX $13.37 0.9300 +7.48%
GTXI $0.75 0.0500 +7.14%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

CBMG $15.00 -0.5200 -3.35%
NWBO $0.77 -0.0250 -3.13%
ARGS $5.78 -0.1800 -3.02%
BCRX $3.22 -0.1000 -3.01%
RDHL $10.88 -0.3000 -2.68%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | Next > | Last >>

OncBioMune Provides Update on Phase 2 Clinical Trials of ProscaVax for Prostate Cancer

(MarketWatch) May 11, 2016 - OncBioMune Pharmaceuticals, Inc. today provides shareholders with an update on the clinical advancement of ProscaVax, the Company's novel cancer vaccine in development for prostate cancer.
read article 



ASCO Urges CMS to Withdraw Flawed Medicare Part B Demo in Formal Comments

(ASCO) May 10, 2016 - In comments submitted today to the Centers for Medicare & Medicaid Services, the American Society of Clinical Oncology underscored the urgent need to advance a more fair and responsible payment system for oncology than what is proposed in the ill-advised Medicare Part B proposal.
read press release 



Exclusive: Medivation Succumbs To Pressure To Explore Sale - Sources

(Reuters) May 10, 2016 - U.S. cancer drug maker Medivation Inc has decided to explore a sale following a $9.3 billion acquisition offer from France's Sanofi SA and interest from other companies, people familiar with the matter said on Monday.
read article 



European Commission Approves the First and Only Immuno-Oncology Combination, Bristol-Myers Squibb’s Opdivo® (nivolumab) + Yervoy® (ipilimumab) Regimen, for Treatment of Advanced Melanoma

(TheStreet) May 11, 2016 - Bristol-Myers Squibb Company announced today that the European Commission (EC) has approved Opdivo in combination with Yervoy for the treatment of advanced (unresectable or metastatic) melanoma in adults, representing the first and only approved combination of two Immuno-Oncology agents in the European Union (EU).
read article 



First Patient Dosed in Phase II Study of L-DOS47 in Non-Small Cell Lung Cancer

(Yahoo! Finance) May 11, 2016 - Helix BioPharma Corp. today announced that the first patient was dosed in the Phase II component of study LDOS002.
read article 



Cerulean Announces First Patient Dosed in Phase 1/2 Trial Evaluating CRLX101 in Combination with LYNPARZA™

(Yahoo! Finance) May 10, 2016 - Cerulean Pharma Inc. today announced that the first patient has been dosed in an open-label, single center Phase 1/2 clinical trial of its lead NDC candidate, CRLX101, in combination with LYNPARZA™ (olaparib) in patients with advanced solid tumors.
read article 



Therapy That Failed With Cancer Could Fight Alzheimer's

(San Diego Union-Tribune) May 11, 2016 - A failed strategy to thwart cancer may find a new life as a therapy for Alzheimer's disease, according to a study by UC San Diego and Harvard scientists.
read article 



Exercise May Reduce the Risk of Cervical Cancer

(RPCI) May 10, 2016 - Even 30 minutes of exercise per week has the potential to significantly reduce a woman’s risk of developing cervical cancer, according to a study from scientists at Roswell Park Cancer Institute (RPCI).
read press release 



Breast Cancer Detection Rates Of Mammogram Readers Don’t Decline Over Time

(University of Warwick [UK]) May 10, 2016 - A new study has found there is no decline over time in the accuracy of medical staff who analyse mammogram scans for indications of breast cancer.
read press release 



Agreement High for Prognostic Cancer Screening Tools

(Doctors Lounge/HealthDay News) May 10, 2016 — For cancer screening in Medicare beneficiaries, there is substantial agreement for different prognostic tools for short- and long-term survival, according to a study published online April 30 in the Journal of the American Geriatrics Society.
read article 



A Better Way to Diagnose and Manage Neuroendocrine Tumors

(SNMMI) May 9, 2016 - A recent study reported in the May issue of the Journal of Nuclear Medicine demonstrates that Ga-68 DOTATATE PET/CT scans are superior to In-111 pentetreotide scans, the current imaging standard in the United States for detecting neuroendocrine tumors (NETS), and could significantly impact treatment management.
read press release 



Potential Target in Treatment of Oral Cancer Discovered

(Boston University) May 10, 2016 - For the first time, researchers have identified a reliable marker (PDGFRB) to detect carcinoma-associated fibroblasts (cells within the tumor that encourage growth and metastasis) (CAFs) in oral cancer tissues.
read press release 



New Target For Lung Cancer Identified

(Institute of Cancer Research [UK]) May 11, 2016 - Researchers have uncovered a key part of a chain reaction of signals that tell some lung cancers to grow. This new insight into a major cancer signalling pathway could prioritise new drug targets.
read article 



Validation of an IHC Screening Tool For ROS1 Gene Rearrangements

(IASLC) May 11, 2016 - Immunohistochemistry (IHC) is an effective tool that can be used for identifying proto-oncogene 1 receptor tyrosine kinase (ROS1) gene rearrangements and screening patients for the administration of the targeted therapy crizotinib, a small-molecule tyrosine kinase inhibitor.
read press release 



Changing the Payment Paradigm

(Pharmaceutical Commerce) May 10, 2016 - Policymakers look at alternative payment models in oncology.
read article 



"Cancer Moonshot" To Start Crowdsourcing Stories, Studies Today On Medium

(USA Today) May 11, 2016 - Vice President Biden's "cancer moonshot" will start crowdsourcing patients' stories and experts' research Wednesday on the blog platform Medium.
read article 



CancerCare® Releases Landmark Patient Access and Engagement Report

(CancerCare) May 11, 2016 - A landmark report illustrating the many physical, emotional, financial, practical and informational needs cancer patients experience during and after clinical treatment was released today by CancerCare, a national nonprofit organization that provides free psychosocial support, education and financial assistance to anyone affected by cancer.
read press release 



U.S. Probes Drugmaker Contracts With Pharmacy-Benefit Managers

(Wall Street Journal) May 10, 2016 - Federal prosecutors are investigating drugmakers’ contracts with companies that manage prescription benefits in the U.S., the latest sign of government scrutiny of how drug companies and industry middlemen do business.
read article (paid subscription required) 



FDA to Re-Evaluate Definition of ‘Healthy'

(ABC News/Associated Press) May 10, 2016 - The Food and Drug Administration will re-evaluate its definition of "healthy," which could eventually upend how a range of foods are marketed.
read article 



Top Funds Said to Tell Drug Leaders to Defend Pricing

(Bloomberg) May 9, 2016 - A group of major U.S. investors, spooked by the recent slump in biotech shares amid political bashing of drug prices, met with a lobbying group and executives in March to urge them to do a better job in defending their industry and take control of the conversation before lawmakers try to regulate price.
read article 



Inefficient Prescribing Costs Billions Of Health Care Dollars

(FoxNews/Reuters) May 10, 2016 - In the U.S. between 2010 and 2012, nearly $73 billion was spent on brand name medications instead of less expensive alternatives, according to a new study.
read article 



Pfizer to Trial Triple-Combination Cancer Treatment

(Financial Times) May 9, 2016 - Pfizer plans to test a combination of three novel cancer drugs in humans next year, as the US drugmaker seeks to make up lost ground in the race to develop a new generation of “immunotherapy” medicines that turn the body into a weapon against tumors.
read article (paid subscription required) 



$8.9M Grant Funds Research On Treatment For One Of Deadliest Cancers

(MUSC) May 9, 2016 - The Hollings Cancer Center has received an $8.9 million grant from the National Cancer Institute to foster collaboration across clinical and laboratory research for the study of signaling in sphingolipids, a class of lipids involved in the growth of solid tumor cancers.
read article 



Stand Up To Cancer to Offer Training Modules for Nurses on Front Lines of Administering New Cancer Therapies

(SU2C) May 9, 2016 - In recognition of Nurses Appreciation Week, Stand Up To Cancer (SU2C) announces the development of a series of Certification for Nursing Education (CNE) training modules by experts from Boston College William F. Connell School of Nursing.
read press release 



Swiss Blood Test for Colorectal Cancer Joins Race of ‘Liquid Biopsies’

(Labiotech.eu) May 9, 2016 - Novigenix has published a validation study of its molecular blood test (Colox) which can reliably detect colorectal cancer at an early stage. Is this the second-place diagnostic in the race for Colorectal cancer blood tests?
read article